Dietary fats promote inflammation in Wistar rats as well as induce proliferation, invasion of SKOV3 ovarian cancer cells.

Journal of Food Biochemistry
Jafar SaeidiAhmad Ghasemi

Abstract

The role of high fat diet (HFD) in ovarian cancer and its underlying mechanisms are poorly known. In current investigation, we investigated inflammatory and oncogenic effect of dietary fats in female Wistar rats and ovarian cancer cell line (SKOV3). The ELISA kits were used for adipokines and inflammatory factors analyses in sera collected from rats fed with high fat diet (SR-HFD). Cell growth, proliferation, apoptosis, migration, and invasion were measured in SKOV3 cells treated with the SR-HFD and FA mix. IL6, IL1β, TNFα, NF-kβ, and p53 expression were measured in cells incubated with the mentioned treatments. Leptin and inflammatory factors increased, while adiponectin decreased in SR-HFD. Moreover, FA mix significantly induced proliferation, migration, and invasion, promoted the expression of inflammatory factors and NF-κB and inhibited apoptosis markers in SKOV3 cells. Taken together, our findings revealed that diet might be a crucial factor in ovarian cancer progression through altering the inflammatory factors. PRACTICAL APPLICATIONS: The HFD-mediated obesity promotes cancer progression in various tissues. This study highlights the progression of inflammation in female Wistar rats and the growth of ovarian cancer cells b...Continue Reading

References

Apr 1, 1969·Acta Medica Scandinavica·P BjörntorpE Varnauskas
Feb 1, 1995·British Journal of Cancer·G ScambiaS Mancuso
Jan 1, 1996·Pharmacology & Therapeutics·R J Norman, M Brännström
Sep 2, 1999·Journal of the National Cancer Institute·R B Ness, C Cottreau
Jun 29, 2004·Journal of Translational Medicine·Ralph S FreedmanEna Wang
Jun 23, 2005·Journal of Translational Medicine·Xipeng WangRalph S Freedman
Oct 4, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·David R HodgeWilliam L Farrar
Mar 30, 2006·British Journal of Cancer·I KelesidisC S Mantzoros
May 25, 2006·Journal of Molecular Endocrinology·R BuettnerL C Bollheimer
Apr 11, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·George YuanRobert A Hegele
Oct 11, 2007·Journal of the National Cancer Institute·Ross L PrenticeRowan T Chlebowski
Dec 7, 2007·The Journal of Allergy and Clinical Immunology·Giamila Fantuzzi
Jul 16, 2008·Pharmaceutical Research·Preetha AnandBharat B Aggarwal
Dec 2, 2008·Nature Reviews. Drug Discovery·Anwesha DeyDavid P Lane
May 21, 2009·Human Molecular Genetics·Annie E Hill-BaskinJoseph H Nadeau
Jan 13, 2010·Cold Spring Harbor Perspectives in Biology·Michael Karin
May 1, 2008·Current Immunology Reviews·Noriko IikuniAntonio La Cava
Jul 16, 2010·The Prostate·Eugene V VykhovanetsSanjay Gupta
Oct 28, 2010·Nutrition Research Reviews·Niloofar Hariri, Louise Thibault
May 19, 2011·Critical Care : the Official Journal of the Critical Care Forum·Katherine RobinsonBala Venkatesh
Jun 3, 2011·The Journal of Clinical Investigation·Carey N Lumeng, Alan R Saltiel
Jan 19, 2013·Arquivos brasileiros de endocrinologia e metabologia·Gilberto Paz-FilhoJulio Licinio
Mar 9, 2013·Biochimica Et Biophysica Acta·Sharon M LouieDaniel K Nomura
Apr 5, 2013·Neoplasia : an International Journal for Oncology Research·Isaiah Gregory SchauerJinsong Liu
Nov 2, 2013·Toxicologic Pathology·L Charles Murtaugh
Jan 1, 2014·Maturitas·Raúl Baena Ruiz, Pedro Salinas Hernández
Apr 15, 2014·Annals of the New York Academy of Sciences·Nathan A Berger
Jul 16, 2014·Oncotarget·Zaid Al-WahabRamandeep Rattan
Sep 5, 2014·Cancer Immunology Research·Yifeng XiaInder M Verma
Sep 26, 2014·Cancer Research·Ravi KasiappanWenlong Bai
Nov 13, 2014·Hormone Molecular Biology and Clinical Investigation·Patricio López-JaramilloStefany Triana-Cubillos
Jul 28, 2016·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Boyun KimYong Sang Song
Nov 3, 2016·Cold Spring Harbor Perspectives in Medicine·Andrei V Gudkov, Elena A Komarova
Jan 12, 2017·São Paulo Medical Journal = Revista Paulista De Medicina·Daniela Mayumi RochaHelen Hermana Hermsdorff

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.